Sodium Citrate Blood-Pack Units, (PL 146 Plastic) (Fresenius Kabi USA, LLC)
Welcome to the PulseAid listing for the Sodium Citrate Blood-Pack Units, (PL 146 Plastic) drug offered from Fresenius Kabi USA, LLC. This Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Fresenius Kabi USA, LLC |
| NON-PROPRIETARY NAME: | Anticoagulant Sodium Citrate Solution |
| SUBSTANCE NAME: | TRISODIUM CITRATE DIHYDRATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2014-09-29 |
| END MARKETING DATE: | 0000-00-00 |
Sodium Citrate Blood-Pack Units, (PL 146 Plastic) HUMAN PRESCRIPTION DRUG Details:
| Item Description | Sodium Citrate Blood-Pack Units, (PL 146 Plastic) from Fresenius Kabi USA, LLC |
| LABELER NAME: | Fresenius Kabi USA, LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 4(g/100mL) |
| START MARKETING DATE: | 2014-09-29 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 63323-505_ccec1a48-d2f4-4130-93d9-d68502321b1d |
| PRODUCT NDC: | 63323-505 |
| APPLICATION NUMBER: | BN770923 |
Other TRISODIUM CITRATE DIHYDRATE Pharmaceutical Manufacturers / Labelers:
